CHAPTER 1. Industry Overview of Cell Line Development Market
1.1. Definition and Scope
1.1.1. Definition of Cell Line Development
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cell Line Development Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cell Line Development MarketByProduct Type
1.2.3. Cell Line DevelopmentMarketBySource
1.2.4. Cell Line DevelopmentMarketByType of Cell Line
1.2.5. Cell Line DevelopmentMarketByApplication
1.2.6. Cell Line DevelopmentMarketBy Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Cell Line Development Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Cell Line Development Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2020
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2. R&D Status of Cell Line DevelopmentMajor Manufacturers in 2020
CHAPTER 5. Cell Line Development Market By Product Type
5.1. Introduction
5.2. Cell Line Development Market Revenue ByProduct Type
5.2.1. Cell Line Development Market Revenue (US$ Mn) and Forecast, By Product Type, 2017-2028
5.2.2. Reagents & Media
5.2.2.1. Reagents & Media Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3. Equipment
5.2.3.1. Equipment Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.2. Incubator
5.2.3.2.1. Incubator Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.3. Centrifuge
5.2.3.3.1. CentrifugeMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.4. Bioreactor
5.2.3.4.1. BioreactorMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.5. Storage Equipment
5.2.3.5.1. Storage EquipmentMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.6. Microscope
5.2.3.6.1. MicroscopeMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.7. Electroporators
5.2.3.7.1. ElectroporatorsMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.8. FACS
5.2.3.8.1. FACSMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.9. Others
5.2.3.9.1. OthersMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.4. Accessories &Consumables
5.2.4.1. Accessories & ConsumablesMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6. Cell Line Development Market Revenue BySource
6.1. Introduction
6.2. Cell Line Development MarketRevenue (US$ Mn)By Source
6.2.1. Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
6.2.2. Mammalian
6.2.2.1. MammalianMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3. Non-Mammalian
6.2.3.1. Non-MammalianMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3.2. Insects
6.2.3.2.1. InsectsMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3.3. Amphibians
6.2.3.3.1. AmphibiansMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7. Cell Line Development Market Revenue By Type of Cell Line
7.1. Introduction
7.2. Cell Line DevelopmentMarket Revenue (US$ Mn) By Type of Cell Line
7.2.1. Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
7.2.2. Recombinant
7.2.2.1. RecombinantMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.3. Hybridomas
7.2.3.1. HybridomasMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.4. Continuous Cell Line
7.2.4.1. Continuous Cell LineMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.5. Primary Cell Line
7.2.5.1. Primary Cell LineMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 8. Cell Line Development Market Revenue By Application
8.1. Introduction
8.2. Cell Line Development MarketRevenue (US$ Mn)By Application
8.2.1. Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
8.2.2. Bioproduction
8.2.2.1. BioproductionMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
8.2.3. Drug Discovery
8.2.3.1. Drug DiscoveryMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
8.2.4. Toxicity Testing
8.2.4.1. Toxicity TestingMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
8.2.5. Tissue Engineering
8.2.5.1. Tissue EngineeringMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
8.2.6. Research
8.2.6.1. ResearchMarket Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 9. North America Cell Line Development Market By Country
9.1. North America Cell Line DevelopmentMarket Overview
9.2. U.S.
9.2.1. U.S.Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
9.2.2. U.S.Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
9.2.3. U.S.Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
9.2.4. U.S.Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
9.3. Canada
9.3.1. Canada Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
9.3.2. Canada Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
9.3.3. Canada Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
9.3.4. Canada Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
9.4. North America PEST Analysis
CHAPTER 10. Europe Cell Line Development Market By Country
10.1. Europe Cell Line DevelopmentMarket Overview
10.2. U.K.
10.2.1. U.K.Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
10.2.2. U.K.Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
10.2.3. U.K.Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
10.2.4. U.K.Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
10.3. Germany
10.3.1. GermanyCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
10.3.2. GermanyCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
10.3.3. GermanyCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
10.3.4. GermanyCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
10.4. France
10.4.1. FranceCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
10.4.2. FranceCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
10.4.3. FranceCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
10.4.4. FranceCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
10.5. Spain
10.5.1. SpainCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
10.5.2. SpainCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
10.5.3. SpainCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
10.5.4. SpainCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
10.6. Rest of Europe
10.6.1. Rest of EuropeCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
10.6.2. Rest of EuropeCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
10.6.3. Rest of EuropeCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
10.6.4. Rest of EuropeCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Cell Line Development Market By Country
11.1. Asia Pacific Cell Line DevelopmentMarket Overview
11.2. China
11.2.1. ChinaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
11.2.2. ChinaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
11.2.3. ChinaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
11.2.4. ChinaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
11.3. Japan
11.3.1. JapanCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
11.3.2. JapanCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
11.3.3. JapanCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
11.3.4. JapanCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
11.4. India
11.4.1. IndiaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
11.4.2. IndiaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
11.4.3. IndiaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
11.4.4. IndiaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
11.5. Australia
11.5.1. AustraliaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
11.5.2. AustraliaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
11.5.3. AustraliaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
11.5.4. AustraliaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
11.6. South Korea
11.6.1. South KoreaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
11.6.2. South KoreaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
11.6.3. South KoreaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
11.6.4. South KoreaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-PacificCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
11.7.2. Rest of Asia-PacificCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
11.7.3. Rest of Asia-PacificCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
11.7.4. Rest of Asia-PacificCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Cell Line Development Market By Country
12.1. Latin AmericaCell Line DevelopmentMarket Overview
12.2. Brazil
12.2.1. BrazilCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
12.2.2. BrazilCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
12.2.3. BrazilCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
12.2.4. BrazilCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
12.3. Mexico
12.3.1. MexicoCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
12.3.2. MexicoCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
12.3.3. MexicoCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
12.3.4. MexicoCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
12.4. Rest of Latin America
12.4.1. Rest of Latin AmericaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
12.4.2. Rest of Latin AmericaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
12.4.3. Rest of Latin AmericaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
12.4.4. Rest of Latin AmericaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Cell Line Development Market By Country
13.1. Middle East & Africa Cell Line DevelopmentMarket Overview
13.2. GCC
13.2.1. GCCCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
13.2.2. GCCCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
13.2.3. GCCCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
13.2.4. GCCCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
13.3. South Africa
13.3.1. South AfricaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
13.3.2. South AfricaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
13.3.3. South AfricaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
13.3.4. South AfricaCell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByProduct Type, 2017-2028
13.4.2. Rest of Middle East & Africa Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast BySource, 2017-2028
13.4.3. Rest of Middle East & Africa Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByType of Cell Line, 2017-2028
13.4.4. Rest of Middle East & Africa Cell Line DevelopmentMarket Revenue (US$ Mn) and Forecast ByApplication, 2017-2028
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Cell Line Development Market
14.1. Cell Line Development Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and ProductEnhancements
14.2.3. Mergers And Acquisition InGlobal Cell Line Development market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Sigma-Aldrich Corp.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Market Revenue (US$ Mn), 2020
15.1.3.2. Sigma-Aldrich Corp. 2020Cell Line Development Business Regional Distribution
15.1.4. Product/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Lonza group AG
15.3. Corning Inc.
15.4. Eurofins
15.5. GE Healthcare
15.6. GenScript Biotech Corporation
15.7. Syngene International Limited
15.8. Novartis
15.9. Samsung Biologics
15.10. Horizon Discovery
15.11. Thermo Fisher Scientific Inc.
15.12. WuXiAppTec
Frequently Asked Questions
How much was the estimated value of the global cell line development market in 2020?
The estimated value of global cell line development market in 2020 was accounted to be US$5,279 Mn.
What will be the projected CAGR for global cell line development market during forecast period of 2021 to 2028?
The projected CAGR of cell line development during the analysis period of 2021 to 2028 is 10.5%.
Which are the prominent competitors operating in the market?
The prominent players of the global cell line developmentmarketinvolve Sigma-Aldrich Corp., Lonza group AG, Corning Inc., Eurofins, GE Healthcare, GenScript Biotech Corporation, Syngene International Limited, Novartis, Samsung Biologics, Horizon Discovery, Thermo Fisher Scientific Inc., and Wuxi AppTec, Inc.
Which region held the dominating position in the global cell line development market?
North America held the dominating share for cell line development during the analysis period of 2021 to 2028
Which region exhibited the fastest growing CAGR for the forecast period of 2021 to 2028?
Asia-Pacific region exhibited fastest growing CAGR for cell line development during the analysis period of 2021 to 2028
What are the current trends and dynamics in the global cell line development market?
Growing prevalence of cancer all over globe, and growing demand for regenerative medicines are the major factors driving the global cell line development market.
By segment source, which sub-segment held the maximum share?
Based on source, mammalian segment held the maximum share for cell line development market in 2020.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
